Breaking News Instant updates and real-time market news.

SNAP

Snap

$17.57

0.5695 (3.35%)

13:30
06/16/17
06/16
13:30
06/16/17
13:30

Snap calls outpace puts 2:1 as shares see strength

Snap calls outpace puts 2:1 as shares see strength. The stock up 67c to $17.67 with help from positive comments from former Yahoo (YHOO) CEO Ross Levinson. In option action, the eight most active contracts in Snap are calls, being led by 5.1K at the Jul 28th 18 call strike. Aug 16 calls, Jul 18 calls, and Jul 17 calls are drawing interest as well. Total volume includes 32K calls and 16K puts.

  • 28

    Jun

  • 19

    Jul

SNAP Snap
$17.57

0.5695 (3.35%)

06/09/17
06/09/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Snap (SNAP) downgraded to Neutral from Buy at Citi with analyst Mark May saying a slower than expected roll-out of new platforms and channels like self-serve is slowing down the pace of monetization growth. 2. Domino's Pizza (DPZ) downgraded to Neutral from Buy at Longbow with analyst Alton Stump saying his checks indicate second quarter domestic franchised comparables are up 6.25%-6.75%, versus consensus of 7.4%, and recommends investors take a pause on putting new money to work given recent share strength. 3. Nordstrom (JWN) downgraded to Neutral from Buy at Guggenheim with analyst Michael Binetti saying he does not see much further upside potential, even in a leveraged buyout scenario. The analyst believes a going private buyer could only pay $46 per share to generate a 10% internal rate of return. 4. Cantel Medical (CMD) downgraded to Hold from Buy at Benchmark with analyst Raymond Myers saying that he is increasingly concerned that its comparisons become tougher in the next two quarters. 5. Endo (ENDP) downgraded to Hold following Opana ER removal from market at Stifel with analyst Annabel Samimy saying Endo's recovery "just got harder" following the FDA's request for the company to voluntarily remove Opana ER from the market. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/09/17
SBSH
06/09/17
DOWNGRADE
Target $20
SBSH
Neutral
Snap downgraded to Neutral from Buy at Citi
Citi analyst Mark May downgraded Snap to Neutral and cut his price target for the shares to $20 from $24. The camera company closed yesterday down 4% to $18.85. A slower than expected roll-out of new platforms and channels like self-serve is slowing down the pace of monetization growth, May tells investors in a research note. Further, he believes investors "may continue to be wary near term" of the company's user growth, which disappointed in Q1. The analyst adds that the IPO lock-up expiration in August will increase the stock available for sale by over 500% or 949M shares. He believes this could pressure the stock.
06/08/17
OPCO
06/08/17
NO CHANGE
Target $23
OPCO
Outperform
Oppenheimer checks show slower adoption by new advertisers for Snap
Oppenheimer analyst Jason Helfstein says his recent channel checks indicate strong growth in existing advertiser spend for Snap, but slower adoption by new advertisers due to platform-specific video ads, limited 3P data and brand safety concerns for user-generated story ads. As a result, the analyst removed $5M from this Q2 revenue estimate to reflect slower than expected advertiser adoption and added the same amount to his Q4 estimate. He expects all of the new advertiser headwinds to be solved over time. Snap's full roll-out of a self-service ad manager in July should accelerate new advertiser adoption in the second half of 2017, Helfstein tells investors in a research note. He keeps an Outperform rating on the shares with a $23 price target.
06/07/17
NOMU
06/07/17
NO CHANGE
Target $14
NOMU
Reduce
Snap download trends deteriorated thus far in Q2, says Nomura Instinet
An analysis of app download data from SensorTower points to year-over-year deterioration in Snapchat download trends through the first two months of Q2, Nomura Instinet analyst Anthony DiClemente tells investors in an intraday research note titled "Snap Back Unlikely in 2Q." He points out that Facebook's (FB) Instagram downloads grew year-over-year in Q2, which the analyst believes suggests competitive pressures may be intensifying for Snap. For April and May, SensorTower has Snap worldwide downloads down 22%. DiClemente keeps a Reduce rating on the shares with a $14 price target. He lowered his 2017 earnings per share estimate for SNAP to ($3.24) from ($2.68) and revenue estimate to $842M from $953M. These estimates are well below the consensus. Snap in midday trading is down 73c to $19.63.

TODAY'S FREE FLY STORIES

CLR

Continental Resources

$56.93

-0.73 (-1.27%)

07:54
01/17/18
01/17
07:54
01/17/18
07:54
Downgrade
Continental Resources rating change  »

Continental Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PXD

Pioneer Natural

$182.51

-3.64 (-1.96%)

07:53
01/17/18
01/17
07:53
01/17/18
07:53
Downgrade
Pioneer Natural rating change  »

Pioneer Natural…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

IPAS

iPass

$0.45

-0.0349 (-7.21%)

07:53
01/17/18
01/17
07:53
01/17/18
07:53
Initiation
iPass initiated  »

iPass initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BYD

Boyd Gaming

$36.16

-0.32 (-0.88%)

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Initiation
Boyd Gaming initiated  »

Boyd Gaming initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$37.92

0.42 (1.12%)

, NURO

NeuroMetrix

$1.72

-0.06 (-3.37%)

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Technical Analysis
Technical Take: NeuroMetrix up sharply, GlaxoSmithKline strategic collaboration »

NeuroMetrix (NURO) was…

GSK

GlaxoSmithKline

$37.92

0.42 (1.12%)

NURO

NeuroMetrix

$1.72

-0.06 (-3.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 25

    Mar

  • 23

    Apr

MOBL

MobileIron

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Initiation
MobileIron initiated  »

MobileIron initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$116.64

-1.53 (-1.29%)

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Downgrade
PPG rating change  »

PPG downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

JEC

Jacobs Engineering

$69.42

-0.14 (-0.20%)

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Hot Stocks
Jacobs wins engineering services agreement from Carcross/Tagish Energy »

Jacobs Engineering Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 07

    Feb

07:50
01/17/18
01/17
07:50
01/17/18
07:50
Conference/Events
UBS REITs analyst holds an analyst/industry conference call »

REITs Analyst Yulico,…

GM

General Motors

$44.19

0.12 (0.27%)

07:49
01/17/18
01/17
07:49
01/17/18
07:49
Periodicals
GM, DHL use Chinese plant to handle flow of parts, Reuters reports »

DHL employees have been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

EGAN

eGain

$5.35

-0.35 (-6.14%)

07:48
01/17/18
01/17
07:48
01/17/18
07:48
Initiation
eGain initiated  »

eGain initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$221.53

0.3 (0.14%)

07:48
01/17/18
01/17
07:48
01/17/18
07:48
Recommendations
Netflix analyst commentary  »

Netflix checks suggest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 22

    Jan

  • 30

    Jan

XRAY

Dentsply Sirona

$65.65

-0.14 (-0.21%)

07:47
01/17/18
01/17
07:47
01/17/18
07:47
Hot Stocks
Dentsply Sirona adds three new board members »

Dentsply Sirona has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:47
01/17/18
01/17
07:47
01/17/18
07:47
General news
Futures suggest rebound from yesterday's dip »

Stock futures are higher…

PSO

Pearson

$9.82

-0.08 (-0.81%)

07:47
01/17/18
01/17
07:47
01/17/18
07:47
Hot Stocks
Pearson: U.S. tax reform to result in one-off deferred tax charge in 2017 »

Pearson says, "Our…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSO

Pearson

$9.82

-0.08 (-0.81%)

07:46
01/17/18
01/17
07:46
01/17/18
07:46
Hot Stocks
Pearson sees FY18 adjusted operating profit GBP520M-GBP560M »

Pearson says, "In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIFI

Boingo Wireless

$21.49

-0.83 (-3.72%)

07:46
01/17/18
01/17
07:46
01/17/18
07:46
Initiation
Boingo Wireless initiated  »

Boingo Wireless initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

PSO

Pearson

$9.82

-0.08 (-0.81%)

07:46
01/17/18
01/17
07:46
01/17/18
07:46
Earnings
Pearson sees FY adjusted EPS above 49p-52p guidance range »

Adjusted earnings per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADNT

Adient

$81.91

-0.51 (-0.62%)

07:45
01/17/18
01/17
07:45
01/17/18
07:45
Technical Analysis
Technical Take: Adient falls sharply in pre-market, analyst action »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

ESPR

Esperion

$71.91

-1.35 (-1.84%)

07:45
01/17/18
01/17
07:45
01/17/18
07:45
Recommendations
Esperion analyst commentary  »

Esperion price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$68.78

-0.48 (-0.69%)

07:44
01/17/18
01/17
07:44
01/17/18
07:44
Recommendations
Lennar analyst commentary  »

Lennar price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NHYDY

Norsk Hydro

$7.60

-0.16 (-2.06%)

07:43
01/17/18
01/17
07:43
01/17/18
07:43
Downgrade
Norsk Hydro rating change  »

Norsk Hydro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FAST

Fastenal

$55.44

-0.15 (-0.27%)

07:43
01/17/18
01/17
07:43
01/17/18
07:43
Earnings
Fastenal reports Q4 EPS 45c ex-tax benefit, consensus 45c »

Management said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

LBTYA

Liberty Global

$36.56

-0.31 (-0.84%)

07:43
01/17/18
01/17
07:43
01/17/18
07:43
Upgrade
Liberty Global rating change  »

Liberty Global upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

, CELG

Celgene

$104.82

-1.18 (-1.11%)

07:42
01/17/18
01/17
07:42
01/17/18
07:42
Recommendations
Juno Therapeutics, Celgene analyst commentary  »

Juno Therapeutics price…

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.